Name: COLL Income Statement - Collegium Pharmaceutical Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

COLL - Collegium Pharmaceutical, Inc.

USD | NASDAQ | Healthcare

COLL Income Statement - Collegium Pharmaceutical Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	193.5	205.4	209.4	188.0	177.8	181.9	159.3	145.3	144.9	149.7	136.7	135.5	144.8	129.6	127.0	123.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013
Revenues
Revenues	796.3	780.6	631.4	566.8	463.9	276.9	310.0	296.7	280.4	28.5	1.7	-	-	-
Cost of Revenue	313.2	317.3	254.1	240.6	254.4	126.3	130.2	193.7	165.7	2.6	0.2	-	-	-
Gross Profit	483.2	463.3	377.3	326.2	209.5	150.6	179.8	103.0	114.7	25.9	1.5	-	-	-
Operating Expenses
Research & Development	-	-	0.0	0.0	4.0	9.5	9.8	10.3	8.7	8.6	14.9	8.0	15.0	14.2
Operating Income
Operating Income	188.8	179.6	169.9	167.0	33.3	17.6	56.2	(23.7)	(20.7)	(75.4)	(94.1)	(26.9)	(17.7)	(16.0)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense
Tax & Net
Income Tax Expense	33.3	29.7	29.4	27.6	(3.8)	(74.9)	0.8	0.0	-	-	-	-	-	-
Net Income From Continuing Ops
Per Share
EPS Basic	2.34	1.98	2.14	1.43	(0.74)	2.05	0.78	(0.68)	(1.19)	-	(3.88)	(1.48)	(22.72)	-
EPS Diluted
Supplementary Data
EBITDA	192.4	183.8	173.8	170.5	36.0	19.4	57.1	(23.0)	(19.6)	(74.9)	(93.4)	(26.7)	(17.5)	(15.9)
EBIT

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	4.0	1.6	1.5	3.5	2.9	2.5	2.1	2.5	2.7	2.4	2.5	2.5	3.0	2.2	1.9	2.2	2.3	2.2	2.1	2.2	2.1	3.3	3.3	4.3
Selling General & Administrative	86.4	67.6	67.1	73.6	76.4	63.1	62.0	43.3	42.0	32.9	35.3	38.2	52.8	38.0	38.4	41.3
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	0.5	0.9	1.0	1.1	1.1	1.0	0.9	1.0	0.9	-	-	-	0.8	-	-	-
Amortization of Intangibles	55.5	-	-	-	55.5	55.5	40.8	34.5	34.5	34.5	36.3	37.5	37.5	-	37.6	37.5	18.9
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	86.4	67.6	67.1	73.3	75.6	60.2	62.0	43.3	42.0	32.9	35.3	38.2	52.8	38.0	38.4	41.3

Operating Income
Operating Income	30.9	60.8	62.1	35.1	21.7	38.1	34.8	47.5	49.5	61.7	45.0	35.6	24.6	11.8	20.5	11.1	(10.0)	(34.1)	14.1	16.4	21.2	15.0	19.6	16.5	5.1	(2.4)	(6.4)	(5.0)	(10.0)	11.0	(11.2)	(7.3)	(13.2)	(17.6)	(13.4)	(21.3)	(23.2)	(27.6)	(26.4)	(24.5)

Non-Operating
Interest Income	-	-	3.1	2.4	2.2	-	3.3	4.4	4.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	15.9	19.3	21.8	20.5	20.8	22.7	18.4	15.6	17.3	19.3	20.8	21.9	21.4	20.6	19.0	17.8	5.8	4.8
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	18.7	29.0	43.4	17.0	3.1	17.3	15.6	29.1	36.6	46.7	28.8	17.8	(17.6)	(7.8)	1.4	(6.6)	(15.8)

Tax & Net
Income Tax Expense	4.2	12.1	11.9	5.0	0.7	4.7	6.2	9.5	8.9	14.8	8.1	4.8	(0.1)	(0.6)	1.0	(1.5)	(2.8)	(13.8)	1.0	(61.9)	(0.2)	-	0.3	0.2	-	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	14.5	17.0	31.5	12.0	2.4	12.5	9.3	19.6	27.7	31.9	20.6	13.0	(17.4)	(7.2)	0.5	(5.2)	(13.1)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	14.5	17.0	31.5	12.0	2.4	12.5	9.3	19.6	27.7	31.9	20.6	13.0	(17.4)	(7.2)	0.5	(5.2)	(13.1)
Net Income Attributable To Parent	14.5	17.0	31.5	12.0	2.4	12.5	9.3	19.6	27.7	31.9	20.6	13.0	(17.4)	(7.2)	0.5	(5.2)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	14.5	17.0	31.5	12.0	2.4	12.5	9.3	19.6	27.7	31.9	20.6	13.0	(17.4)	(7.2)	0.5

Per Share
EPS Basic	0.45	-	1.00	0.38	0.08	-	0.29	0.60	0.86	-	0.61	0.38	(0.51)	-	0.01	(0.15)	(0.39)	-	0.23	2.06	0.45	-	0.33	0.23	0.01	-	(0.18)	(0.14)	(0.29)	-	-	-	-	-	-	-	(0.79)	-	(1.13)	(1.05)
EPS Diluted	0.40	-	0.84	0.34	0.07	-	0.27	0.52	0.71	-	0.53	0.34	(0.51)	-	0.01	(0.15)	(0.39)	-
Shares Basic	32.1	-	31.6	31.8	31.8	-	32.3	32.4	32.3	-	33.7	34.6	34.3	-	34.1	34.0	33.7	-
Shares Diluted	40.1	-	39.4	39.1	32.8	-	40.2	40.4	41.4	-	42.1	42.8	34.3	-	34.6	34.0	33.7	-

Supplementary Data
EBITDA	31.4	61.7	63.1	36.2	22.8	39.2	35.8	48.4	50.4	-	-	-	25.4	-	-	-	(9.3)	-	-	-	21.6	-	-	-	5.3	-	-	-	(9.8)	-	-	-	(12.7)	-	-	-	(23.0)	-	-	-
EBIT	30.9	60.8	62.1	35.1	21.7	38.1	34.8	47.5	49.5	61.7	45.0	35.6	24.6	11.8	20.5	11.1	(10.0)	(34.1)	14.1